Drug maker Zandu Pharmaceutical Works today announced a net profit of Rs 7.97 crore for the fourth quarter ended March 31, 2009, up more than seven-fold over the corresponding period a year ago.
The company had earned a net profit Rs 1.13 crore during the same period last year, Zandu Pharmaceutical Works informed the Bombay Stock Exchange in a regulatory filing.
Total income increased to Rs 38.34 crore in the quarter under review from Rs 28.88 crore in the same quarter last fiscal, it said.
For the year ended March 31, 2009, net profit of the company rose to Rs 26.18 crore from Rs 16.40 crore in the previous year.
Total income of the company jumped up to Rs 165.51 crore in the year under review from Rs 137.23 crore in FY08.
Shares of the company closed at Rs 8,181.70, marginally down from the previous close on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app